ArticleMicroplastics and nanoplastics2025
The Toxicity of Microplastics Explorer (ToMEx) 2.0.
Article in Microplastics and nanoplastics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Global microplastic pollution poses a disproportionate reproductive threat to critically endangered marine fishes.Environmental science and ecotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
70 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2021 the Toxicity of Microplastics Explorer (ToMEx, https://microplastics.sccwrp.org) was released as an open source, open access database and web application for microplastics toxicity. Since then, it has been utilized by the microplastic research community for the exploration, visualization, and analysis of toxicity data for both hazard characterization and risk assessment. The peer-reviewed literature has continued to grow exponentially, making ToMEx out-of-date. To ensure the continued utility of ToMEx, an international crowd-sourcing approach was utilized to update ToMEx by extracting data from additional studies published since the original release. Through this process, both the aquatic and human health ToMEx databases roughly doubled in size, and modest increases in data diversity (e.g., number of species represented, types of test particles) were observed in the aquatic organisms database. However, most trends (e.g., greater toxicities observed with smaller particle sizes, lack of dose-response data etc.) observed in the first iteration of ToMEx remained constant. A previously developed framework for deriving ecological health-based microplastic thresholds using species sensitivity distributions was reapplied to determine how thresholds and their associated uncertainty intervals would change following the database update. Twelve new studies passed minimum screening criteria and were deemed fit for the purpose of threshold derivation. The addition of new data allowed for the separation of freshwater and marine compartments which had previously been combined due to a lack of applicable toxicity data for freshwater species. When molecular and cellular level endpoints were included, freshwater thresholds were comparable or increased from values calculated using previous data (-5 to 2.5-fold change) whereas marine thresholds dramatically decreased (-5000 to -29-fold change). However, when endpoints were restricted to organism and above, marine and freshwater thresholds were comparable to those calculated previously (-20 to 14-fold change). Confidence intervals for both marine and freshwater thresholds remained wide. The doubling of the database increases the value of ToMEx for researchers, particularly those focused on characterizing hazards associated with microplastics. Its utility remains limited for environmental managers as 89% of studies in ToMEx 2.0 failed to meet minimum screening criteria for threshold derivation, highlighting the need to generate fit-for-purpose toxicity data for threshold development. However, ToMEx continues to be a useful research tool, and future iterations could become even more powerful through novel artificial intelligence applications to streamline data curation and even predict toxicological outcomes. Supplementary Information: The online version contains supplementary material available at 10.1186/s43591-025-00145-6.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.